Strauss Troy Listed as a 2018 Best Law Firm by U.S. News – Best Lawyers®
Elizabeth M. Reeder was invited by the Dean of NKU’s Chase Law School to give a seminar at the Lunsford Academy for Business Law.
Bill Williamson was been invited to speak at two seminars for private companies in October. The seminars focused on basic estate planning matters for professionals and employees of the host companies. Bill’s practice focuses on the areas of real estate law, corporate law and entity formation, estate planning, probate and general business law. Bill’s business …Read More
Whether buying or selling, there are three areas where difficulties occur in Ohio residential real estate transactions: Residential Property Disclosure Form; earnest money deposit; and timing and deadlines regarding inspection of the property. While specific terms of each contract will control the transaction, consider these general observations. The Residential Property Disclosure Form. Both the Ohio …Read More
Strauss Troy is seeking a part-time Court House Clerk for its downtown Cincinnati office. Primary responsibilities: Courthouse filings/Runner Must be available to work Monday through Friday 10 a.m. to 4:30 p.m. Qualifications: Able to get along with a variety of people at courthouses as well as in the office Must be organized and timely Knowledge …Read More
Strauss Troy is pleased to announce that 14 of our attorneys have been recognized as The Best Lawyers in America 2017
Strauss Troy will present two in-house seminars on Thursday, October 12, 2017, beginning at 8:30 a.m.
Strauss Troy partner Timothy B. Theissen has been named to the Board of Trustees of the Children’s Home of Northern Kentucky.
Millennials are generally defined as those aged 18 to 34. Estate planning is rarely a priority for people in this age group, especially those who don’t have children or own a sports car collection. Even those who have started families or own significant assets tend to avoid the notion of a sudden health scare. However, …Read More
The Food and Drug Administration (FDA) has just issued a warning that JOHNSON & JOHNSON’S diabetes drug Invokana® presents a significant risk of causing foot or leg amputations. The FDA’s warning comes after two clinical trials showing foot and leg amputations occurred about twice as often in patients taking the diabetes drug Invokana®. The FDA …Read More